Trinity Biotech | TRIB - Operating Expenses


Trinity Biotech reported $14.82M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Bayer EUR 10.2B 523M Sep/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
EDAP TMS EUR 21.81M 2.26M Jun/2025
J&J USD 18.97B 2.38B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Siemens EUR 18.86B 2.24B Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Tosoh JPY 225.35B 3.7B Sep/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025
Veracyte USD 108.76M 7.09M Sep/2025